相关实验视频

Updated: Sep 13, 2025

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

针对自身免疫性肝炎的非侵入性评估策略

David Jerez Diaz¹, Patrick Twohig²

¹Department of Internal Medicine, Florida State University, Sarasota Memorial Hospital, Sarasota, FL 34239, United States.

World journal of hepatology

|August 1, 2025

概括

纤维检测和过渡性弹性成像对于检测肝纤维化和自身免疫性肝炎 (AIH) 中的炎症是有效的. 这些非侵入性测试可以补充肝脏活检,以更好地管理AIH.

科学领域:

肝病学和免疫学肝病学和免疫学
诊断准确性研究诊断准确性研究

背景情况:

评估肝纤维化对于管理自身免疫性肝炎 (AIH) 是至关重要的,但由于复杂的诊断标准和炎症,侵袭性肝脏活检通常是依赖的.
非侵入性诊断方法,如FibroTest-Actitest和过渡性弹性体检正在被评估为生物检查的替代方案或补充.

研究的目的:

评估FibroTest-Actitest的诊断性能,暂时弹性学和纤维化-4指数与组织学评估对比.
为了比较这些非侵入性方法在检测AIH患者肝纤维化和炎症活性方面的准确性.

主要方法:

利用Obuchowski测量来评估诊断的准确性.
与组织学参考标准比较FibroTest-Actitest,振动控制的短暂弹性学和纤维化-4指数.
采用贝叶斯隐性类模型进一步验证非侵入性测试可靠性.

主要成果:

在检测肝纤维化时,FibroTest和振动控制的短暂弹性图表表表现出优于纤维化-4指数的性能.
与传统生物标志物相比,Actitest对炎症活性进行了更好的估计.
贝叶斯模型支持AIH管理的非侵入性测试的可靠性.

结论:

非侵入性诊断工具在治疗自身免疫性肝炎方面显示出显著的前景.
这些测试有可能补充肝脏活检,特别是长期疾病监测.
通过可靠的非侵入性诊断来优化AIH管理至关重要.

关键词:

行为测试行为测试自体免疫性肝炎是一种自身免疫性肝炎.纤维检测纤维检测纤维化-4指数指数肝脏活检活检是什么意思非侵入性测试试验无侵袭性测试试验短暂的弹性图形 (elastography) 是一种短暂的弹性图形.

更多相关视频

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

相关概念视频

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...